Optimal autologous peripheral blood progenitor cell mobilization involves more than the CD34+yield

Biol Blood Marrow Transplant. 2014 Jan;20(1):2-3. doi: 10.1016/j.bbmt.2013.11.008. Epub 2013 Nov 14.

Author

Omotayo Fasan¹

Affiliation

¹ Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina. Electronic address: omotayo.fasan@carolinashealthcare.org.

PMID: 24240016
DOI: 10.1016/j.bbmt.2013.11.008

No abstract available

Publication types

Comment

MeSH terms

Etoposide / pharmacology*
Female
Granulocyte Colony-Stimulating Factor / pharmacology*
Hematopoietic Stem Cell Mobilization / methods*
Hematopoietic Stem Cell Transplantation*
Hematopoietic Stem Cells / drug effects*
Humans
Lymphoma, Non-Hodgkin / therapy*
Male

Substances

Granulocyte Colony-Stimulating Factor
Etoposide